Dr. Ferrari on LBH589 and Bicalutamide in CRPC

Anna C. Ferrari, MD, professor, co-director, GU Research Program, Departments of Medicine (Cancer Center) and Medicine (Residency Program), discusses a study that examined the efficacy of LBH589 and bicalutamide in patients with castration-resistant prostate cancer (CRPC).

Видео Dr. Ferrari on LBH589 and Bicalutamide in CRPC автора Euro-Car Community Connection